AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
55.05
-1.06 (-1.89%)
Feb 27, 2026, 4:00 PM EST - Market closed
AnaptysBio Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for AnaptysBio stock have an average target of 62.2, with a low estimate of 20 and a high estimate of 100. The average target predicts an increase of 12.99% from the current stock price of 55.05.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jan 20, 2026.
Analyst Ratings
The average analyst rating for AnaptysBio stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 4 | 4 |
| Buy | 5 | 6 | 6 | 6 | 6 | 4 |
| Hold | 3 | 3 | 3 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 12 | 12 | 11 | 12 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $55 → $78 | Buy | Maintains | $55 → $78 | +41.69% | Jan 20, 2026 |
| UBS | UBS | Hold → Strong Buy Initiates $20 → $70 | Hold → Strong Buy | Initiates | $20 → $70 | +27.16% | Jan 7, 2026 |
| Barclays | Barclays | Buy Maintains $70 → $55 | Buy | Maintains | $70 → $55 | -0.09% | Dec 17, 2025 |
| Stifel | Stifel | Strong Buy Maintains $80 → $56 | Strong Buy | Maintains | $80 → $56 | +1.73% | Dec 11, 2025 |
| Wedbush | Wedbush | Buy Reiterates $50 | Buy | Reiterates | $50 | -9.17% | Nov 24, 2025 |
Financial Forecast
Revenue This Year
214.97M
from 91.28M
Increased by 135.51%
Revenue Next Year
127.21M
from 214.97M
Decreased by -40.82%
EPS This Year
-1.29
from -5.12
EPS Next Year
-4.67
from -1.29
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 242.1M | 152.3M | ||||
| Avg | 215.0M | 127.2M | ||||
| Low | 158.8M | 87.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 165.3% | -29.2% | ||||
| Avg | 135.5% | -40.8% | ||||
| Low | 73.9% | -59.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.51 | -2.37 | ||||
| Avg | -1.29 | -4.67 | ||||
| Low | -3.08 | -7.67 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.